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Numerous reports have documented a high occurrence of sleep difficulties in drug-
dependent populations, prompting researchers to characterize sleep profiles and 
physiology in drug abusing populations. This mini-review examines studies indicating 
that drug-dependent populations exhibit alterations in sleep homeostatic and restoration 
processes in response to sleep deprivation. Sleep deprivation is a principal sleep 
research tool that results in marked physiological challenge, which provides a means to 
examine sleep homeostatic processes in response to extended wakefulness. A report 
from our laboratory demonstrated that following recovery sleep from sleep deprivation, 
brain high-energy phosphates particularly beta–nucleoside triphosphate (beta-NTP) are 
markedly increased as measured with phosphorus magnetic resonance spectroscopy 
(MRS). A more recent study examined the effects of sleep deprivation in opiate-
dependent methadone-maintained (MM) subjects. The study demonstrated increases in 
brain beta-NTP following recovery sleep. Interestingly, these increases were of a 
markedly greater magnitude in MM subjects compared to control subjects. A similar 
study examined sleep deprivation in cocaine-dependent subjects demonstrating that 
cocaine-dependent subjects exhibit greater increases in brain beta-NTP following 
recovery sleep when compared to control subjects. The studies suggest that sleep 
deprivation in both MM subjects and cocaine-dependent subjects is characterized by 
greater changes in brain ATP levels than control subjects. Greater enhancements in 
brain ATP following recovery sleep may reflect a greater disruption to or impact of sleep 
deprivation in drug dependent subjects, whereby sleep restoration processes may be 
unable to properly regulate brain ATP and maintain brain high-energy equilibrium. These 
studies support the notion of a greater susceptibility to sleep loss in drug dependent 
populations. Additional sleep studies in drug abusing populations are needed, 
particularly those that examine potential differential effects of sleep deprivation. 
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Numerous reports have documented a high occurrence of sleep difficulties in drug-dependent 
populations[1,2,3], subsequently prompting sleep researchers to characterize sleep profiles and sleep 
physiology in drug-abusing populations. For example, poor sleep has been widely reported in cocaine-
abusing populations, although studies of cocaine dependence have reported conflicting results of both 
hypo- and hypersomnia [4,5,6,7,8,9], which underscores the difficulty disseminating the pharmacological 
effects of acute drug usage on sleep from underlying changes in sleep homeostasis and abstinence. 
Similarly, numerous studies of alcohol, nicotine, marijuana, and opiate dependence have reported findings 
of poor sleep and insomnia, particularly during early abstinence[5,10,11,12,13,14,15,16,17,18]. Drug-
dependent individuals actively in treatment for dependence also report various sleep difficulties. For 
example, sleep difficulties and insomnia particularly afflict individuals in methadone 
treatment[19,20,21,22,23,24]. Further investigation of sleep disturbances in drug-abusing populations is 
needed in order to gain understanding of how sleep-altered processes influence behavioral and cognitive 
performance, as well as potentially contributing to the perpetuation of drug-taking behaviors.   
Sleep deprivation is a principal sleep research tool that results in marked behavioral challenges as 
evidenced by increased daytime sleepiness and task-specific changes in behavioral and cognitive 
performance[25,26,39,40]. Although sleep deprivation does not always result in impaired or altered 
performance, functional magnetic resonance imaging studies have identified performance-related changes 
in regional brain activation indicative of compensatory recruitment of functional brain regions[41,42,43]. 
Studies have also begun to characterize a direct role of multiple neurotransmitter systems in the regulation 
of sleep[32,33,34]. For example, animal studies have demonstrated increases in serotonergic activity in 
response to sleep deprivation in brain areas such as the dorsal raphe, hippocampus, and frontal 
cortex[35,36,37]. Additionally, these noted enhancements of serotonergic activity have been associated 
with the antidepressant responses associated with sleep deprivation reported in humans[35,36,37,38].  
The resultant behavioral and physiological challenge of sleep deprivation provides a means of 
examining sleep homeostatic processes in response to extended wakefulness. The wakefulness 
presumably results in an extended period of cerebral metabolic activity and demand, allowing the 
examination of recovery sleep following sleep deprivation[27]. Recent research has begun to identify 
brain mechanisms associated with the prolonged metabolic activity of sleep deprivation as well as the 
enhanced restorative quality of recovery sleep[3,28,29,30,31]. Hence, the study of recovery sleep 
provides insight into mechanisms potentially involved in the restorative qualities of sleep. Previous 
magnetic resonance spectroscopy (MRS) imaging studies have examined brain markers of neurochemical 
abnormalities, neuronal integrity, and metabolic alterations in drug-abusing or -dependent 
populations[44,45,46,47,48]. For instance, studies have used phosphorus (
31P) MRS brain imaging to 
examine cerebral high-energy phosphate and phospholipid metabolite changes that result from long-term 
drug abuse and/or withdrawal in substance abusers[49,50,51]. The technique of 
31P MRS imaging allows 
the direct measurement of brain high-energy phosphates such as alpha-, beta-, and gamma-nucleoside 
triphosphate (NTP)[52].  While both cytidine and guanosine triphosphates are present in the NTP 
resonance, the NTP resonance is derived primarily of adenosine triphosphate (ATP) and is at relatively 
higher concentrations (∼1.8 mM) in the brain[53]. Beta-NTP may be of primary interest as beta-NTP is 
unique to NTP, whereas alpha- and gamma-NTP also contribute to nucleoside diphosphates (NDP). 
31P 
MRS imaging provides a direct measure of NTP levels and of the currently available methods for the 
assessment of in vivo brain adenosine metabolites, 
31P MRS imaging is the most commonly used[54].  
A report from our laboratory previously examined how brain ATP levels fluctuate over the course of 
a total sleep deprivation paradigm in healthy subjects[55]. Specifically, this study demonstrated that 
following recovery sleep from sleep deprivation, brain high-energy phosphates, particularly beta-NTP, are 
markedly increased. The increase in ATP following recovery sleep may indicate a sleep homeostatic 
process by which the restorative processes of recovery sleep require utilization of brain ATP with the 
prolonged metabolic demands necessary to sustain wake-time function during sleep deprivation. These 
findings are consistent with animal studies indicating a reduction or depletion of brain glycogen 
stores[29,56,57]. Typically, the oxidation of glycogen is critical to the synthesis of ATP, which is utilized 
in response to metabolic demands. The neuronal utilization of brain ATP results in ATP metabolism and Trksak et al.: Sleep Homeostasis and Drug Dependence  TheScientificWorldJOURNAL (2007) 7(S2), 217–222
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the by-products adenosine diphosphate (ADP) and inorganic phosphate[58,59]. Animal studies have 
provided strong evidence that sleep deprivation results in a build up of brain adenosine[29,42,60], which 
is associated with enhanced sleep pressure that results in an increased drive to sleep. Similarly, a 
reduction of brain glycogen stores[56], as well as a potential interaction with glucocorticoids[57], have 
also been demonstrated in response to sleep deprivation. Findings of brain energy changes after recovery 
sleep support theories that wake-time activity is sustained by brain bioenergetic restorative sleep[29,61].  
 
 
FIGURE 1. Illustrates global brain 
31P MRS imaging spectra indicating phosphorus-containing peaks obtained following the first 
night of recovery sleep in control subject (top) and MM subject (bottom).  
Two more recent studies from our laboratory have begun to identify and characterize how drug-
dependent populations respond to the prolonged wakefulness of total sleep deprivation, measuring both 
sleep physiology with polysomnography and in vivo measurements of brain high-energy phosphates with 
31P MRS imaging[62,63]. One study examined the response to sleep deprivation in opiate-dependent 
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methadone-maintained (MM) subjects. Similar to the findings in control subjects, results indicated that 
MM subjects exhibited the greatest changes in brain ATP in the morning following recovery sleep (Fig. 
1). Interestingly, MRS imaging data revealed that the enhancements in global brain beta-NTP levels over 
the course of the sleep deprivation paradigm were of a markedly greater magnitude in MM subjects 
compared to control subjects. A second study examined the effects of sleep deprivation in cocaine-
dependent subjects. Most notably, cocaine-dependent subjects, similar to MM subjects, exhibited 
markedly greater enhancements of brain beta-NTP following recovery sleep when compared to control 
subjects. These preliminary data suggest that sleep deprivation in both MM subjects and cocaine-
dependent subjects is characterized by underlying changes in brain ATP levels involved in sleep 
homeostasis and sleep restoration. 
These brain MRS imaging data examining brain bioenergetics support the notion of a greater 
susceptibility to sleep loss in drug-dependent populations, marked by alterations in sleep homeostatic and 
restorative processes. Greater enhancements in brain ATP following recovery sleep may reflect a greater 
disruption to or impact of sleep deprivation in drug-dependent subjects, whereby sleep-restoration 
processes may be unable to regulate brain ATP properly and maintain brain high-energy equilibrium. A 
greater susceptibility to sleep deprivation may have profound functional consequences in cognitive and 
behavioral performance related to shift workers. Hence, additional sleep studies in drug-abusing 
populations are needed, particularly those that examine potential differential effects of sleep deprivation 
or sleep restriction. Additionally, insomnia has been associated with the occurrence of psychiatric 
disorders, depression, and a decline in executive function[64,65,66,67], and may have a relationship as 
well to decision making and the continuation of drug-taking behaviors. Greater susceptibility to sleep 
deprivation is also critical to the understanding of sleep processes in drug-dependent individuals in active 
treatment such as MM and how persistent drug abuse-related insomnia may increase relapse potential[24]. 
Elucidating the effects of methadone early in treatment and through the duration of therapy may be useful 
in extracting factors leading to failed treatment and relapse. These studies highlight the importance of 
developing novel clinical drug-abuse treatment approaches involving detailed monitoring and regulation 
of sleep behavior potentially with sleep pharmacotherapy.  
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